Evaluation of MGBG (methyl-Glyoxal Bis-Guanylhydrazone; Methyl GAG) in Solid Tumors and Refractory Hematologic Malignancies. Closed to GU, GI and Breast: 5/80

Methyl-glyoxal bis guanyl hydrazone (Methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group

WA Knight III;C Fabian;JJ Costanzi;SE Jones;CA Coltman Jr Investigational New Drugs 1:235-237

Methyl-glyoxal Bis-Guanylhydrazone (Methyl-GAG) in the management of Non-Hodgkin's lymphoma (NHL)

JG Kuhn;WA Knight III;TM McDaniel;CA Coltman Jr;JP Whitecar;C Fabian;JJ Costanzi ASCO #C-635

Phase I-II trial of Methyl-GAG in advanced colon cancer: A Southwest Oncology Group pilot study.

JW Myers;WA Knight III;RB Livingston;CJ Fabian;J Costanzi Cancer Clin Trials 4:277-279

Methyl-Glyoxal Bis-Guanylhydrazone (Methyl-GAG, MGBG) in advanced colon carcinoma.

WA Knight III;RB Livingston;JJ Costanzi;RE Paque AACR #656

Methyl-Glyoxal Bis-Guanylhydrazone (Methyl GAG, MGBG) in advanced renal carcinoma.

WA Knight III;RB Livingston;CJ Fabian;JJ Costanzi ASCO #C-190

Chemotherapy of advanced renal adenocarcinoma with methylglyoxal-bis-guanylhydrazone (methyl- GAG).

RF Todd;MB Garnick;GP Canellos AACR 21:340

Phase I-II trial of Methyl-GAG: A Southwest Oncology Group pilot study.

WA Knight III;RB Livingston;C Fabian;J Costanzi Cancer Treat Rep 63(11-12):1933-1937

Methyl-Glyoxal-Bis-Guanylhydrazone (Methyl-GAG, MGBG) in advanced human malignancy.

W Knight;R Rivingston;C Fabian;J Costanzi ASCO #C-115